Pain management in Brooklyn involves the use of a variety of treatments to alleviate pain and stiffness caused by osteoarthritis (OA). One of the options that provide fast relief for knee pain due to OA is Monovisc. A high molecular weight hyaluronan injection, Monovisc is recommended for patients who have failed to respond adequately to knee pain treatment options such as conservative non-pharmacologic therapy and simple analgesics such as acetaminophen.
Hyaluronic acid is a naturally occurring agel-like fluid found in the synovial fluid surrounding joints. It acts as a lubricant to enable the bones to move smoothly over each other and as a shock absorber for joint loads. Usually, people with OA have a lower than normal concentration of hyaluronic acid in their joints, resulting in joint pain and stiffness. When monovisc is injected directly into the area around the knee joint, it restores the cushioning and lubricating properties of the knee joint, reducing thepain and improving mobility. This single injection viscosupplement can relieve OA-related knee pain for up to six months.
OA of the knees is a major cause of disability in the United States. It is estimated that over 30 million Americans are affected by OA. The factors that cause deterioration of the knee joint are: wear and tear, aging, heredity, traumatic injury, weight gain, repetitive stress injuries and gender. Infact, this condition is more common in women than men, especially in women over the age of 50.
Monovisc is a non-avian sourced viscosupplementation derived from bacterial cells. Here are some key facts about this FDA-approved knee pain treatment option:
- Contains the highest amount of hyaluronan available for a single injection
- Provides pain relief without the use of additional medications
- Ideal option for osteoarthritis patients with sensitivities or allergies to birds or chickens, eggs and feathers
- Long lasting relief through 26 weeks
- Better patient compliance with a single injection than a multi injection product
- Administered in the doctor’s office
- No confirmed pseudoseptic reactions reported
Monovisc is administered directly to the knee joint. The area where the needle is to be inserted is cleaned with an antiseptic solution. Sometimes, a local anesthetic injection is administered into the skin and superficial tissues to minimize the pain that occurs during the actual joint injection process. Once an ideal point is located, monovisc is injected into the joint.
Following the joint injection, the knee joint should be rested. Patients are advised to avoid doing any strenuous activities such as jogging, tennis or prolonged weight bearing for about 48 hours.
Monovisc treatment is safe. The only adverse events observed in the original clinical studies were arthralgia or joint pain, joint swelling, pain at the injection site, and effusion.
This non-drug therapy is not administered to the patients with:
- Known hypersensitivity to hyaluronate formulations or to gram positive bacterial proteins
- Infections or skin diseases in the area of the injection site or joint
- Known systemic bleeding disorders
If you are looking for OA-related knee pain treatment and think that you may benefit from Monovisc injections, approach a reliable multispecialty healthcare providing pain management services in Brooklyn. Pain management doctors will evaluate your symptoms and determine if you are a good candidate for the hyaluronic acid injection. Other options available for knee pain at these centers include: physical therapy, chiropractic care, TENS (Transcutaneous Electrical Nerve Stimulation), NSAIDs, weight loss, ice and heat application, anti-inflammation medication, and ultrasound guided joint injections.